Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia

被引:65
作者
Polymeropoulos, Mihael H. [1 ]
Licamele, Louis [1 ,2 ]
Volpi, Simona [1 ]
Mack, Kendra [1 ]
Mitkus, Shruti N. [1 ]
Carstea, Eugene D. [1 ]
Getoor, Lise [2 ]
Thompson, Andrew [1 ]
Lavedan, Christian [1 ]
机构
[1] Vanda Pharmaceut Inc, Rockville, MD 20850 USA
[2] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA
关键词
Antipsychotic action; Lipid homeostasis; Gene expression; Pathogenesis; RAT FRONTAL-CORTEX; EICOSAPENTAENOIC ACID; GENE-EXPRESSION; PHOSPHOLIPID ABNORMALITIES; 1ST-EPISODE SCHIZOPHRENIA; DEFICIENCY SYNDROME; HORMONE MODULATION; ESTROGEN-RECEPTOR; SYMPTOM REMISSION; CLINICAL-TRIAL;
D O I
10.1016/j.schres.2008.11.025
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
For decades, the dopamine hypothesis has gained the most attention in an attempt to explain the origin and the symptoms of schizophrenia. While this hypothesis offers an explanation for the relationship between psychotic symptoms and dopamine kinetics, it does not provide a direct explanation of the etiology of schizophrenia which remains poorly understood. Consequently, current antipsychotics that target neurotransmitter receptors, have limited and inconsistent efficacy. To gain insights into the mechanism of action of these drugs, we studied the expression profile of 12,490 human genes in a cell line treated with 18 antipsychotics, and compared it to that of a library of 448 other compounds used in a variety of disorders. Analysis reveals a common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol, which is discussed in the context of a lipid hypothesis where alterations in lipid homeostasis might underlie the pathogenesis of schizophrenia. This finding may help research aimed at the development of novel treatments for this devastating disease. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 63 条
  • [31] Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes
    Lum, PY
    Armour, CD
    Stepaniants, SB
    Cavet, G
    Wolf, MK
    Butler, JS
    Hinshaw, JC
    Garnier, P
    Prestwich, GD
    Leonardson, A
    Garrett-Engele, P
    Rush, CM
    Bard, M
    Schimmack, G
    Phillips, JW
    Roberts, CJ
    Shoemaker, DD
    [J]. CELL, 2004, 116 (01) : 121 - 137
  • [32] Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease
    Maida, Mary E.
    Hurley, Sean D.
    Daeschner, Jo Anna
    Moore, Amy H.
    O'Banion, M. Kerry
    [J]. BRAIN RESEARCH, 2006, 1103 : 164 - 172
  • [33] Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications
    McNamara, Robert K.
    Jandacek, Ronald
    Rider, Therese
    Tso, Patrick
    Hahn, Chang-Gyu
    Richtand, Neil M.
    Stanford, Kevin E.
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 91 (1-3) : 37 - 50
  • [34] NASRALLAH HA, 1993, PSYCHIAT CLIN N AM, V16, P269
  • [35] Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8
  • [36] L2L: a simple tool for discovering the hidden significance in microarray expression data
    Newman, JC
    Weiner, AM
    [J]. GENOME BIOLOGY, 2005, 6 (09)
  • [37] Ntambi JM, 1999, J LIPID RES, V40, P1549
  • [38] Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results
    Peet, M
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 69 (06): : 477 - 485
  • [39] DOPAMINERGIC AND LIGAND-INDEPENDENT ACTIVATION OF STEROID-HORMONE RECEPTORS
    POWER, RF
    MANI, SK
    CODINA, J
    CONNEELY, OM
    OMALLEY, BW
    [J]. SCIENCE, 1991, 254 (5038) : 1636 - 1639
  • [40] Puri BK, 2000, INT J CLIN PRACT, V54, P57